Glasdegib Maleate
Who holds supplier records for Glasdegib Maleate? No organisation holds a current US Type II DMF or EU CEP for Glasdegib Maleate in the registers PharmaTek covers.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Glasdegib Maleate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/glasdegib-maleate
Reading the evidence
- No current DMF or CEP on record
The covered registers hold no supplier record for this substance. This is not evidence that no one makes it: suppliers may file under another name, sell outside the US and EU, or use an ASMF.
Current records (0)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Glasdegib Maleate. Country is the organisation's recorded country, not necessarily the manufacturing site.
Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Glasdegib Maleate is a small molecule inhibitor of the Hedgehog signaling pathway used in the treatment of certain types of cancer, including acute myeloid leukemia (AML). It functions by binding to and inhibiting the Smoothened (SMO) receptor, which plays a critical role in this pathway.
Chemical identity
- IUPAC name
- 1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea;(Z)-but-2-enedioic acid
- Canonical SMILES
- CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N.C(=C\C(=O)O)\C(=O)O
- InChIKey
- VJCVKWFBWAVYOC-UIXXXISESA-N
- Synonyms
- Daurismo API, daurismo, pf-04449913 maleate
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Hedgehog Pathway Inhibitor
- Mechanism of action
- Smoothened Receptor Antagonists
Therapeutic areas
Record history
PharmaTek records which organisations hold a current DMF or CEP for Glasdegib Maleate every week, starting 23 Oct 2026. Additions and lapses will appear here from the next weekly release.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Do you supply Glasdegib Maleate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.